The company has substantially boosted the progress of an new treatment for amyloid heart disease, utilizing the compound. Preliminary patient information suggests potential outcomes for individuals suffering with this https://bridgebio554753.loginblogin.com/50343997/bridgebio-advances-attr-cm-therapy-using-the-therapy